tbuckley/cabot-search huggingface dataset:
SAT-310 Immune profiling of peripheral and intrahepatic B cells in chronic hepatitis B
Authors: Anna Pocurull Aparicio, Maria Saez-Palma, Thais Leonel, Sara Battistella, Maëlle Locatelli, Ángela Sanzo-Machuca, Simon Fletcher, Mala Maini, Xavier Forns, Sabela Lens
Journal: Journal of Hepatology (2025)
SAT-322 Nucleos(t)ide analogue cessation outcomes in non-cirrhotic patients with HBeAg-negative chronic hepatitis B
Authors: Zeynep Melekogèlu Ellik, Fatma Tugèçe Sèah Ünal, Özge Koç, Serkan Duman, Sevinç Tugèçe Güvenir, Volkan Yılmaz, Mesut Gümüsèsoy, Abdullah Mübin Özercan, Emin Bodakçi, Ramazan Erdem Er, Hale Gokcan, Ramazan Idilman
Journal: Journal of Hepatology (2025)
FRI-512 TAVI in liver transplant candidates: a retrospective analysis from a high-volume transplant center
Authors: Marta Sánchez-Ric, Giulia Pagano, Ander Regueiro, Marc Giménez-Milà, Annabel Blasi, Pablo Ruiz, Jordi Colmenero, Gonzalo Crespo
Journal: Journal of Hepatology (2025)
SAT-326 HLA associations with specific anti-nuclear antibody reactivity in people living with primary biliary cholangitis
Authors: Aisha Alawi, Jinguo Wang, Shani Nagler, Madeline Cameron, Claire Gage, Ripandeep Kaur, Aliya Gulamhusein, Gideon M. Hirschfield
Journal: Journal of Hepatology (2025)
SAT-145-YI Clinical trajectories of patients with cirrhosis and ascites receiving long-term albumin. A proposal for a personalized management based on real-world experience
Authors: Enrico Pompili, Giulia Iannone, Salvatore Piano, Pierluigi Toniutto, Antonino Lombardo, Stefania Gioia, Giacomo Zaccherini, Marta Tonon, Roberta Gagliardi, Maurizio Baldassarre, Greta Tedesco, Lorenzo Lani, Valeria Guarneri, Vito Di Marco, Silvia Nardelli, Vincenza Calvaruso, Davide Bitetto, Paolo Angeli, Paolo Caraceni
Journal: Journal of Hepatology (2025)
THU-184 Synergy between ornithine phenylacetate and strategies targeting endotoxemia with either a toll-like receptor 4 antagonist (TAK-242) or Yaq-001 for the treatment of hyperammonemia in cirrhosis and ACLF
Authors: Tingting Qi, Annarein Kerbert, Fausto Andreola, Rajiv Jalan
Journal: Journal of Hepatology (2025)
WED-285-YI Real-world evidence shows comparable Bulevirtide effectiveness in hepatitis D patients with and without cirrhosis: results from the prospective nationwide D-Shield multicenter study
Authors: Maria Paola Anolli, Elisabetta Degasperi, Giampiero D’Offizi, Alessia Rianda, Alessandro Loglio, Mauro Vigano, Alessia Ciancio, Yulia Troshina, Maurizia Brunetto, Barbara Coco, Serena Zaltron, Anna Cambianica, Laura Turco, Loredana Sarmati, Michele Milella, Pierluigi Toniutto, Letizia Marinaro, Francesco Paolo Russo, ANDREA Gori, Ivana Rita Maida, Alessandro Federico, Teresa Santantonio, Edoardo Giovanni Giannini, Gabriella Verucchi, Filomena Morisco, Alessandra Mangia, Stella de Nicola, Biagio Pinchera, Monia Maracci, Antonietta Romano, Saveria Lory Croce’, Pietro Gatti, Rosa Zampino, Marcello Persico, Pietro Pozzoni, Angelo Pan, Adriano Pellicelli, Nicola Coppola, Francesca Pileri, Paola Vitiello, Matteo Tonnini, Eleonora Grassi, Alessandro Soria, Massimo Puoti, Pietro Lampertico
Journal: Journal of Hepatology (2025)
WED-310 A mathematical viral load model characterises the exposure- response relationship between bulevirtide and hepatitis delta virus and identifies the minimum duration of on-treatment viral load monitoring required for accurate prediction of long-term virologic response
Authors: Parag Kumar, Anna Mc Laughlin, Nieves Velez de Mendizabal, Luzelena Caro, David Damoiseaux, Amos Lichtman, Dmitry Manuilov, Renee-Claude Mercier, Liyun Ni, Yang Liu, Hongmei Mo, Ana Ruiz-Garcia
Journal: Journal of Hepatology (2025)
FRI-279 Adaptive NK cells are expanded in CMV-positive patients with chronic hepatitis B or hepatitis D and remain elevated after initiation of antiviral treatment
Authors: Gliga Smaranda, Wiebke Moskorz, Alexander Killer, Jan Köhler, Ai Uehara, Andreas Walker, Nadine Lübke, Maximilian Paul Damagnez, Hans H. Bock, Tom Luedde, Jörg Timm
Journal: Journal of Hepatology (2025)
LBP-016 Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study
Authors: Jidong Jia, Bingliang Lin, Peng Hu, Qing Xie, Mark Douglas, Fangfang Lv, Won Young Tak, Ke Cao, Chong Zhu, Yue Wu, Xiaofei Chen, David Margolis, Qing Zhu
Journal: Journal of Hepatology (2025)
FRI-518-YI Depression is highly prevalent amongst patients listed for liver transplant and unrelated to liver disease severity
Authors: Victoria Kronsten, Alexandra Frolkis, Alison Taylor, Jemma Day, Paul McKie, Catherine Polling, Racquel Beckford, Niloufar Safinia, Maria Guerra Veloz, Deepak Joshi, Michael Heneghan, Abid Suddle, Kosh Agarwal, Varuna Aluvihare, Debbie L. Shawcross, Claire Kelly
Journal: Journal of Hepatology (2025)
FRI-253 Large spatial variation of intrahepatic HDV RNA levels without association with HBV core or S RNA levels in patients with HDV induced cirrhosis
Authors: Gustaf Rydell, Lucia Gonzales Strömberg, Johan Ringlander, Maria Andersson, Catarina Skoglund, Staffan Nilsson, Maria Castedal, Magnus Lindh
Journal: Journal of Hepatology (2025)
SAT-152 Optimising management of patients discharged from hospital following an acute decompensation of cirrhosis – a multicentre UK perspective
Authors: Giovanna McGinty, Benjamin Allen, Kate Simpson, Kelly de Stadler, Emily Boyd, Jessie Khoo, Kartikeya Khanna, Tareq Alhor, Luis Oliveira, Lancy Rodrigues, Anastasia Oates, James Maurice, Ankur Srivastava, Moby Joseph, Terence Farrant, Robbie Adamson, Mohsan Subhani, Kohilan Gananandan
Journal: Journal of Hepatology (2025)
SAT-366 Relative exchangeable copper: an accurate biomarker for the diagnosis of Wilson disease
Authors: Karen Dons, Camilla Lorenzen, Clàudia García-Solà, Xavier Forns, Frederik Kirk, Emilie Munk Lynderup, Karina Rewitz, Anna Soria, Sergio Rodriguez-Tajes, Lene Christensen, Tua Gyldenholm, Peter Nissen Bjerring, Anna Miralpeix, Merceè Torra, Peter Ott, Thomas Damgaard Sandahl, Zoe Mariño
Journal: Journal of Hepatology (2025)
SAT-511-YI Extracellular nicotinamide adenine dinucleotide as an independent prognostic marker for long-term survival after liver transplantation
Authors: Can Kamali, Kaan Kamali, Philipp Brunnbauer, Al-Hussein Saqr, Naomi Chioma Okpala, Sue Easaw, Eriselda Keshi, Igor Sauer, Johann Pratschke, Felix Krenzien
Journal: Journal of Hepatology (2025)
OS-053-YI Periodontitis drives steatotic liver disease progression via a microbiome-dependent oral-gut-liver circuit
Authors: Shahrzad Ghadirzad, Astrid Devriese, Qusay Salih, Mohammed Alatter, Renzhi Li, Maria Backhaus, Madhuri Haque, Lu Jiang, Julius Jaeger, Mohamed Ramadan Mohamed, Mona Peltzer, Sara Setlaoui, Theresa HildegardWirtz, Maike Rebecca Pollmanns, Ina Bergheim, Achim Gronow, Till Strowig, Nikolaus Gaßler, Julia Wollenhaupt, Sonja Vondenhoff, Heidi Noels, Joachim Jankowski, Marta Rizk, Sihem Brenji, Michael Wolf, Marek Weiler, Fabian Kiessling, Carolin V. Schneider, Stefan Wolfart, Taskin Tuna, Kai Markus Schneider
Journal: Journal of Hepatology (2025)
THU-138 Albumin infusion improves albumin binding capacity in patients with cirrhosis and MHE on gut-specific therapy
Authors: Anna Mestre, Raquel Horrillo, Andrew Fagan, Ruben Sabido, Jordi Vidal, Ricardo Gonzalo, Maria Isabel Bravo, Montserrat Costa, Jasmohan Bajaj
Journal: Journal of Hepatology (2025)
OS-007 E2F1-driven metabolic dysregulation is involved in hippo pathway-driven cholangiocarcinoma progression
Authors: Kendall Alfaro-Jiménez, Mikel Ruiz de Gauna, Ane Nieva-Zuluaga, Maider Apodaka-Biguri, Irene Olaizola, Enara Markaide, Laura Izquierdo-Sánchez, Colin Rae, Francisco González-Romero, Paul Gómez-Jauregui, Natalia Sainz-Ramirez, Beatriz Gómez Santos, Xabier Buque, Igor Aurrekoetxea, Igotz Delgado, Idoia Fernández-Puertas, Ainhoa Iglesias, Colm O. Rourke, Pedro M. Rodrigues, Jesper Andersen, Diego Calvisi, Jennifer Morton, Chiara Braconi, Ana Zubiaga, Jesus M. Banales, Patricia Aspichueta
Journal: Journal of Hepatology (2025)
OS-050-YI Unravelling the therapeutic potential of novel peptides derived from the human gut microbiome in mouse models of MASLD and acute liver injury
Authors: Javier Martínez-García, Mario Fernández-Sanz, José Carlos Royo Sanz, Álvaro Blanes-Rodríguez, Sandra Melitón Barbancho, Natalia Sanchez-Romero, Naiara Beraza, Pedro Baptista
Journal: Journal of Hepatology (2025)
LBP-033 Rapid HBsAg declines and HBsAb seroconversion observed with a single dose of VRON-0200 plus Tobevibart and Elebsiran: preliminary results of a VRON-0200 combination treatment from a phase 1b study for functional cure in chronically HBV-infected patients
Authors: Edward J. Gane, Grace Lai-Hung Wong, Sue Currie, Andrew Luber, Marie Bonhomme, Tien Huey Lim
Journal: Journal of Hepatology (2025)
WED-044 Microbial changes resulting from vertical sleeve gastrectomy attenuate obesity by modulating bile acid metabolism and the intestinal farnesoid X receptor‒fibroblast growth factor 15/19 axis
Authors: Yi Xia, Jinpu Yang, Weixin Cheng, Zhening Liu, Ling Yang, Qien Shen, Yujie Liang, Hangkai Huang, Minjie Chen, Feng Ji, Chengfu Xu
Journal: Journal of Hepatology (2025)
THU-225-YI Systematic screening for HBV, HCV and HIV in hospitalised psychiatric patients: a feasible approach on the road towards elimination of viral hepatitis
Authors: Marie Coessens, Hannes Ruymbeke, Jeoffrey Schouten, Ilse Velghe, Jeroen Kleinen, Lieven de Weirdt, Ann Berens, Manuel Morrens, Marianne Destoop, Jeroen Decoster, Wim Verlinden
Journal: Journal of Hepatology (2025)
SAT-481-YI Performance of six biomarkers compared to histological fibrosis stage as surrogate markers of clinical endpoints in drug trials of patients with MetALD and ALD - a dual biopsy study
Authors: Ellen Lyngbeck Jensen, Maja Thiele, Nikolaj Torp, Stine Johansen, Johanne Kragh Hansen, Camilla Dalby Hansen, Mette Lehmann Andersen, Georg Semmler, Katrine Thorhauge, Helle Schnefeld, Ida Falk Villesen, Katrine Bech, Peter Andersen, Diana Julie Leeming, Morten Karsdal, Katrine Lindvig, Sönke Detlefsen, Aleksander Krag, Mads Israelsen
Journal: Journal of Hepatology (2025)
WED-195-YI Frequency and impact of early and sustained hepatic recompensation after TIPS
Authors: Sophia Geißelbrecht, Martin Kabelitz, Jonna Friederike Zimmermann, Anja Tiede, Laura Buttler, Hannah Rieland, Jim Benjamin Mauz, Matti Peperhove, Christine Falk, Heiner Wedemeyer, Lisa Sandmann, Benjamin Maasoumy
Journal: Journal of Hepatology (2025)
WED-486 First construction and validation of new circulating markers (NITs) to assess the risk of early-fibrosis (eF) occurrence in outpatients with type-2 diabetes (T2D) and elevated transaminases
Authors: Thierry Poynard, Olivier Deckmyn, Valentina Peta, Raluca Pais, Judith Aron-Wisnewsky, Karine Clement, Jean-Michel Oppert, Laurent Castera, Vlad Ratziu
Journal: Journal of Hepatology (2025)
TOP-377 The “LITMUS metabolic-dysfunction associated steatotic liver disease intention-to-treat” (LiMITT) score: a machine learning proteomic tool to select patients for therapy
Authors: Anastasia Resteu, Akhil Rajan, Kristy Wonders, Alasdair Blain, Jörn M. Schattenberg, Manuel Romero-Gómez, Mattias Ekstedt, Annalisa Berzigotti, Andreas Geier, Sven Francque, Jeremy Cobbold, Michael Pavlides, Jerome Boursier, Hannele Yki-Järvinen, Detlef Schuppan, Michael Allison, Guruprasad Aithal, A.G. (Onno) Holleboom, Carla Yunis, Helena Cortez-Pinto, George Papatheodoridis, Salvatore Petta, Javier Crespo, Elisabetta Bugianesi, Vlad Ratziu, Ann K Daly, Dina Tiniakos, Paolo Missier, Simon Cockell, Quentin Anstee
Journal: Journal of Hepatology (2025)
THU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma
Authors: Agavni Mesropian, Albert Gris-Oliver, Ugne Balaseviciute, Martí Torres-Marcen, Jordi Abril-Fornaguera, Marta Piqué-Gili, David Camell, Judit Peix, Elisa Fernández-Martínez, Júlia Huguet-Pradell, Ieva Keraite, Roger Esteban-Fabró, Takayuki Kimura, Alka Potdar, Marina Barcena-Varela, Katherine E. Lindblad, Amaia Lujambio, Ernesto Guccione, Swan N Thung, Daniela Sia, Roser Pinyol, Josep Llovet
Journal: Journal of Hepatology (2025)
WED-407 Are doppleralterations of the liver prognostic markers for MASLD Severity? How do doppler results correlate with transient elastography and anthropometric data?
Authors: Teodor-Marcel Puiu, Simona Ioanitescu, Mircea Istrate, Simu Razvan-Ioan, Andreea Simu, Laura Iliescu
Journal: Journal of Hepatology (2025)
WED-433-YI Translating genetic information into clinical practice: Improved decision-making in advanced fibrosis assessment
Authors: Dong Yun Kim, Hyun-Soo Zhang, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Hyun Woong Lee, Heon Yung Gee, Jung Il Lee, Jun Yong Park
Journal: Journal of Hepatology (2025)
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort
Authors: Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, Gauri Wechalekar, Aref Al-Kali, Carla R Toop, Patricia Greipp, Monika M Kutyna, Aasiya Matin, Dariusz Ladon, Antoine Saliba, Dong Chen, Kebede Begna, Anna Brown, Danielle Rud, Mark R Litzow, William J Hogan, Peter Bardy, Talha Badar, Sharad Kumar, David T Yeung, Mrinal M Patnaik, James M Foran, Rong He, Naseema Gangat, Mehrdad Hefazi, Hamish S Scott, Cecilia Y Arana Yi, Hassan Alkhateeb, Abhishek A Mangaonkar, Daniel Thomas, Christopher N Hahn, Attilio Orazi, Daniel A Arber, Chung Hoow Kok, Ayalew Tefferi, Devendra Hiwase
Journal: Blood Cancer Journal (2025)

Abstract The World Health Organization (WHO-5) and International Consensus Classification (ICC) acknowledge the poor prognosis of TP53 -mutated ( TP53 mut ) myeloid neoplasm (MN). However, there are substantial differences between the two classifications that may lead to under- or overestimation of the prognostic risk. We retrospectively applied WHO-5 and ICC to 603 MN cases harboring TP53 mut (variant allele frequency, VAF ≥ 2%). WHO-5 and ICC would not classify 64% and 20% of these cases as TP53 mut MN, respectively. Moreover, of those classified, 67.5% would be classified discrepantly. Primary drivers of discrepancies included: (i) prognostic importance of TP53 mut acute myeloid leukemia (AML), (ii) interaction of the blast percentage and allelic status, (iii) 17p.13.1 deletion detected by cytogenetics, (iv) complex karyotype (CK) as multi-hit equivalent, and (v) TP53 mut VAF threshold, we analyzed survival outcomes of each of these groups with an aim to provide clarity. TP53 mut AML was associated with significantly poor survival compared to TP53 -wild type TP53 wt AML, myelodysplasia-related (AML, MR 4.7 vs . 18.3 months; P &lt; 0.0001), supporting its inclusion within TP53 mut MN as a distinct subentity. Secondly, the survival of TP53 mut with blast 10–19% was poor regardless of the allelic status. Thirdly, for cases with a single TP53 mut with VAF &lt; 50%, 17p13.1 del or CK serve as practical surrogates of biallelic inactivation, obviating the need for an additional copy number analysis. Finally, TP53 mut AML, MDS multi-hit/multi-hit equivalent with VAF &lt; 10% had significantly poorer survival compared to TP53 mut MDS VAF &lt; 10% without CK and 17p del, and were comparable to those with VAF ≥ 10% (14.1 vs . 48.8 vs .7.8 months, P &lt; 0.0001). Collectively, these findings address key areas of contention and provide valuable insights that will guide future revisions of the WHO and ICC classifications.
FRI-455-YI The impact of donor and recipient HSD17B13, PNPLA3 and TM6SF2 genotype on post-transplant fibrosis, steatosis and survival in liver transplant recipients
Authors: Maria Rosina Troppmair, Lukas Oberhuber, Lukas Forer, Sebastian Schoenherr, Bernhard Glodny, Benjamin Henninger, Christian Kremser, Herbert Tilg, Heinz Zoller, Benedikt Schaefer
Journal: Journal of Hepatology (2025)
THU-355 Predictors of response to steroids in children and adolescents with treatment naïve severe autoimmune hepatitis
Authors: Samannay Das, Tamoghna Biswas, Rajeev Khanna, Vikrant Sood, Bikrant Bihari Lal, Seema Alam, Anmol Anmol
Journal: Journal of Hepatology (2025)
SAT-243 Analysis of liver pathological characteristics and influencing factors in patients with an inactive HBsAg carrier status
Authors: Shan Ren, Xinyang Zhang, Sujun Zheng, Rongshan Fan, Faqing Ruan, Wenqi Huang, Haibing Gao, Xiulan Xue, Fang Yang, Xin-Yue Chen
Journal: Journal of Hepatology (2025)
TOP-266 Association between sustained virological response and adverse liver-related outcomes in patients with decompensated HCV cirrhosis
Authors: Lisa M. van Velsen, Lisette Krassenburg, Grishma Hirode, Kosh Agarwal, Graham R. Foster, Zillah Cargill, Raoel Maan, Michael P. Manns, Heiner Wedemeyer, Markus Cornberg, Robert J. de Knegt, Gonzalo Crespo, José Luis Calleja Panero, Alnoor Ramji, Giuseppina Brancaccio, Maria Cristina Morelli, Ilaria Lenci, Chiara Mazzarelli, Raffaella Viganò, Paolo Angeli, Patrizia Burra, Gabriella Verucchi, Maria Francesca Donato, Paola Carrai, Silvia Martini, Paolo Caraceni, Francesco Paolo Russo, Harry L.A. Janssen, Bettina E. Hansen, Adriaan J. van der Meer, Jordan J. Feld, Milan J. Sonneveld
Journal: Journal of Hepatology (2025)
SAT-303 Comprehensive analysis of the intrahepatic immune microenvironment and gene expression profiles in a large cohort of patients with untreated hepatitis B virus infection
Authors: Maria Stella Franzè, Pascale Maille, Stefano Caruso, Julien Calderaro, Yasmine Bouda, Anna Sessa, Stéphane Chevaliez, Patrick Ingiliz, Teresa Pollicino, Giovanni Raimondo, Jean-Michel Pawlotsky, Vincent Leroy, Giuliana Amaddeo
Journal: Journal of Hepatology (2025)
FRI-097 Bridging and long-term impact of pre-orthotopic liver transplant transjugular intrahepatic portosystemic shunt (TIPS) creation: a propensity-matched analysis using the united network for organ sharing (UNOS) database
Authors: Mohammad Mirza-Aghazadeh-Attari, Peiman Habibollahi, Saher Sabri, Emil Cohen, Nima Kokabi, Juan Camacho, Pejman Radkani, Rohit Satoskar, Arul Thomas, Bill Majdalany, Wael Saad, Nariman Nezami
Journal: Journal of Hepatology (2025)
THU-150 Comparative analysis of surrogate markers of intestinal permeability, bacterial translocation, and gut vascular barrier damage across different stages of cirrhosis
Authors: Haedge Frederic, Philipp Reuken, Johanna Reißing, Karsten Große, Mick Frissen, Majda El Hassani, Andreas Stallmach, Tony Bruns
Journal: Journal of Hepatology (2025)
THU-036-YI Integrating spatial lipidomics with imaging mass cytometry: a novel approach for metabolic profiling of liver fibrosis
Authors: Aleksandra Gruevska, Elena Perpinan, Robert D. Goldin, Mark R. Thursz, Matthew Hoare, Niloufar Safinia, Joram Posma, Zoe Hall
Journal: Journal of Hepatology (2025)
SAT-207 High mortality of further decompensation of liver cirrhosis: validation study
Authors: Petra Dinjar Kujundžić, Frane Pastrovic, Mislav Barišic-Jaman, Marko Milosevic, Stela Bukvicè Milosevic, Josip Stojic, Viktoria Skurla, David Dohoczky, Stjepan Budisa, Alan Ayoub, Sandro Kukic, Ivica Grgurevic
Journal: Journal of Hepatology (2025)
THU-048 Cell-type specific roles of TGF-β2 signaling in cholestatic liver disease progression and therapeutic targeting
Authors: Ida Harst, Seddik Hammad, Chenhao Tong, Jan Albin, Carolina De La Torre, Maria Reich, Verena Keitel-Anselmino, Thomas Weiss, Christoph Schramm, Trine Folseraas, Matthias Ebert, Steven Dooley, Nadia Meindl Beinker, Anne Dropmann
Journal: Journal of Hepatology (2025)
FRI-440 The role of extracellular ATP (ATPe) in the progression of metabolic dysfunction – associated steatotic liver disease (MASLD)
Authors: Vanessa García-Fernández, Antonio Gil-Gómez, Rocío Munoz-Hernández, Sheila Gato-Zambrano, Ángela Rojas Álvarez-Ossorio, Isabel Fernández-Lizaranzu, M. Carmen Rico, Rocío Gallego-Durán, Douglas Maya-Miles, Raquel Millan, Manuel Romero-Gómez
Journal: Journal of Hepatology (2025)
LBP-001 Preclinical profiling of ABI-6250, a first-in-class oral therapeutic candidate for chronic hepatitis
Authors: Marc P. Windisch, Nuruddin Unchwaniwala, Jinghu Carl Li, Joseph Tan, Ariel Tang, Yanhong Zhu, Francielle Tramontini Gomes de Sousa, Heidi Contreras, Dinara Azimova, Kirsten Stray, Lewyn Li, Peter Haggie, Gene Schulze, Michael Shen, Jiaxin Yu, Michel Perron, Michael A. Walker, William E. Delaney, Min Zhong
Journal: Journal of Hepatology (2025)
OS-019 A large multicentre hepatitis B cohort study in the United Kingdom highlights high rates of comorbidity associated with liver disease outcomes
Authors: Tingyan Wang, Yun Jung Kim, Jakub Jaworski, Ben Glampson, Dimitri Papadimitriou, Erik Mayer, Stacy Todd, Karl McIntyre, Andrew Frankland, Hizni Salih, Gail Roadknight, Stephanie Little, Theresa Noble, Kinga A. Várnai, Zakary Warsop, Cai Davis, Ashley I. Heinson, Michael George, Florina Borca, Timothy Roberts, Baptiste B. Ribeyre, Louise English, Leilei Zhu, William Frisby, John Taylor, Sarah Montague, Alex Waldren-Glenn, Felicity Evison, Zohur Miah, Victoria Day, Kerrie Woods, Jim Davies, Stephen D. Ryder, Ryan M. Buchanan, Alexander Stockdale, Nicholas Easom, Salim I. Khakoo, Eleni Nastouli, Graham S. Cooke, William Gelson, Ahmed M. Elsharkawy, Philippa C. Matthews, Eleanor Barnes
Journal: Journal of Hepatology (2025)
THU-030 Risk factor awareness for liver disease in four United States cities
Authors: Trenton M White, Scott Isaacs, Norah Terrault, Mary E. Rinella, Alina M Allen, Naim Alkhouri, Meena Bansal, Michael Charlton, Ira Jacobson, Sonal Kumar, Mazen Noureddin, Silvana Pannain, Ayman El-Mohandes, Jeffrey Lazarus
Journal: Journal of Hepatology (2025)
FRI-133 Immunoprofiling-based machine learning model predicts outcomes to pembrolizumab plus lenvatinib in patients with unresectable hepatocellular carcinoma
Authors: Pei-Chang Lee, Po-Yu Li, Cheng-Yun Lee, Shian-Ren Lin, Chi-Jung Wu, Ya-Wen Hung, Jun-Wen Chan, Yu-Hua Chen, Hsien-Chen Mon, Chieh-Ju Lee, Chen-Ta Chi, I-Cheng Lee, Ming-Chih Hou, Yee Chao, Jan-Mou Lee, Yi-Hsiang Huang
Journal: Journal of Hepatology (2025)
SAT-323 Prognostic value of factor VIII, D-Dimer, and high mutation risk variants in re-thrombosis risk stratification for non-cirrhotic splanchnic vein thrombosis
Authors: Anna Baiges, Bogdan Procopet, Luis Téllez, Elba Llop Herrera, Anna Darnell, Maria Ángeles García-Criado, Fanny Turon, Oana Nicoara-Farcau, Héleène Larrue, Valeria Perez, Meritxell Nomdedeu, Juan Carlos Reverter, Alberto Alvarez, Dolors Colomé, Marta Garrote, Monica López, Sonia Torres, Sarah Shalaby, Asunción Ojeda, Lara Orts, José Luis Calleja Panero, Christophe Bureau, Agustín Albillos, Virginia Hernández-Gea, Juan Carlos García-Pagán
Journal: Journal of Hepatology (2025)
THU-437 Association of alpha-1 antitrypsin Pi*Z allele and disease severity in metabolic dysfunction-associated steatotic liver disease
Authors: Kaela Miller, Eduardo Vilar Gomez, Niharika Samala, Tiebing Liang, Raj Vuppalanchi, Samer Gawrieh, Rohit Loomba, Naga Chalasani
Journal: Journal of Hepatology (2025)
FRI-237 Sustained off-treatment inhibition of HBV replication and HBsAg levels after long-term treatment with ABI-4334 in differentiated HepaRG cells and primary human hepatocytes
Authors: Maud Michelet, Audrey Diederichs, Camille Pascarel, Nuruddin Unchwaniwala, Anaëlle Dubois, Sarah Heintz, William E. Delaney, Kathryn M. Kitrinos, Fabien Zoulim, Barbara Testoni
Journal: Journal of Hepatology (2025)
SAT-248-YI End of treatment anti-HBc IgG and HBcrAg predict severe flares after nucleos(t)ide analogue withdrawal in CHB – interim analysis from the multicenter prospective COIN-B trial
Authors: Arno Furquim d’Almeida, Axelle Vanderlinden, Stefan Bourgeois, Jean-Pierre Mulkay, Thomas Sersté, Struyve Mathieu, Baro Deressa, Dirk Sprengers, Marie de Vos, Jos Callens, Bao Shihao, Hendrik Reynaert, Pierre Deltenre, Filip Janssens, Sergio Negrin-Dastis, Peter Stärkel, Hans Orlent, Guy van Roey, Xavier Verhelst, Christophe Moreno, Jean Delwaide, Christophe van Steenkiste, Wim Verlinden, Isabelle Colle, Marie-Laure Plissonnier, Barbara Testoni, Fabien Zoulim, Veerle Matheeussen, Thomas Vanwolleghem
Journal: Journal of Hepatology (2025)